Amanda Seiz

Amanda Seiz has extensive experience in clinical operations and project management. Amanda is currently the Senior Director - Clinical Operations Head for Oncolytic Virus Programs at Imugene Limited since October 2021. Prior to that, they worked as a Sr. Level Clinical Operations Consultant from June 2021 to October 2021. From 2019 to 2021, they served as the Senior Director - Head of Clinical Operations at WindMIL Therapeutics. Amanda was also the Senior Project Director at Precision Oncology from 2017 to 2021. Before that, they held the position of Associate Director, Clinical Operations at MedImmune from 2014 to 2017. Amanda started their career in project management at ICON Clinical Research from 2011 to 2014 and was a Senior Clinical Project Manager at inVentiv Clinical Solutions from 2010 to 2011. Amanda began their work in the field of clinical studies as a Sr. Manager at Astellas Pharma from 2005 to 2010. Amanda's experience showcases their expertise in clinical operations and project management across various pharmaceutical and biotech companies.

Amanda Seiz obtained a Bachelor's degree in Zoology/Animal Biology from Eastern Illinois University.